Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Hony Capital Affiliates Seek $260 Million From CSPC Share Sale

Oct. 10 (Bloomberg) -- Hony Capital Ltd. affiliates are seeking about $260 million by selling shares in CSPC Pharmaceutical Group Ltd., terms for the transaction show.

Jinling Investment Ltd. and Joyful Horizon Ltd. are offering 500 million shares in CSPC, a Chinese maker of vitamins and generic drugs, at HK$4.04 to HK$4.10 apiece, according to a term sheet obtained by Bloomberg News. The stock, which was halted today pending a statement on the share sale, closed at HK$4.35 in Hong Kong yesterday.

Morgan Stanley is arranging the transaction, according to the terms. Victoria Li, a Hony spokeswoman, didn’t immediately return a call seeking comment.

Hony, a Chinese private equity firm, raised HK$1.2 billion ($155 million) selling CSPC shares in April, data compiled by Bloomberg show.

CSPC shares jumped 95 percent in 2013. The drug maker generated 71 percent of its revenue last year from China and 11 percent from America, according to data compiled by Bloomberg.

To contact the reporters on this story: Fox Hu in Hong Kong at fhu7@bloomberg.net; Zijing Wu in Hong Kong at zwu17@bloomberg.net

To contact the editor responsible for this story: Philip Lagerkranser at lagerkranser@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.